CA2210538A1 - Eukaryotic initiation factor 5a (eif-5a) mutants - Google Patents

Eukaryotic initiation factor 5a (eif-5a) mutants

Info

Publication number
CA2210538A1
CA2210538A1 CA002210538A CA2210538A CA2210538A1 CA 2210538 A1 CA2210538 A1 CA 2210538A1 CA 002210538 A CA002210538 A CA 002210538A CA 2210538 A CA2210538 A CA 2210538A CA 2210538 A1 CA2210538 A1 CA 2210538A1
Authority
CA
Canada
Prior art keywords
eif
gene
dna
protein
cdna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002210538A
Other languages
English (en)
French (fr)
Inventor
Joachim Hauber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9502771.0A external-priority patent/GB9502771D0/en
Priority claimed from GBGB9513505.9A external-priority patent/GB9513505D0/en
Application filed by Individual filed Critical Individual
Publication of CA2210538A1 publication Critical patent/CA2210538A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002210538A 1995-02-13 1996-02-12 Eukaryotic initiation factor 5a (eif-5a) mutants Abandoned CA2210538A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9502771.0A GB9502771D0 (en) 1995-02-13 1995-02-13 Organic compounds
GBGB9513505.9A GB9513505D0 (en) 1995-07-03 1995-07-03 Organic compounds
GB9513505.9 1995-07-03
GB9502771.0 1995-07-03

Publications (1)

Publication Number Publication Date
CA2210538A1 true CA2210538A1 (en) 1996-08-22

Family

ID=26306494

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002210538A Abandoned CA2210538A1 (en) 1995-02-13 1996-02-12 Eukaryotic initiation factor 5a (eif-5a) mutants

Country Status (15)

Country Link
EP (1) EP0811060A1 (cs)
JP (1) JPH10509327A (cs)
KR (1) KR19980702160A (cs)
CN (1) CN1173897A (cs)
AU (1) AU4665196A (cs)
BR (1) BR9606951A (cs)
CA (1) CA2210538A1 (cs)
CZ (1) CZ255397A3 (cs)
FI (1) FI972763A7 (cs)
HU (1) HUP9801681A3 (cs)
IL (1) IL117113A0 (cs)
NO (1) NO973679L (cs)
PL (1) PL321239A1 (cs)
SK (1) SK109997A3 (cs)
WO (1) WO1996025492A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001551A2 (en) * 1997-06-30 1999-01-14 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel inhibitor of cellular proliferation
US7166467B2 (en) * 2001-07-23 2007-01-23 Senesco Technologies, Inc. Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
US7968523B2 (en) * 2001-07-23 2011-06-28 Senesco Technologies, Inc. Method for inducing apoptosis using apoptosis-specific EIF5-A
US7217517B2 (en) * 2001-07-23 2007-05-15 Senesco Technologies, Inc. Nucleic acids, polypeptides, and methods for modulating apoptosis
US7381708B2 (en) 2001-07-23 2008-06-03 Sensco Technologies, Inc. Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye
US6867237B1 (en) * 2001-07-23 2005-03-15 Senesco Technologies, Inc. DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans
JP4754819B2 (ja) * 2002-05-07 2011-08-24 セネスコ テクノロジーズ，インコーポレイティド アポトーシス調節に関する核酸、ポリペプチド及び方法
TW200427695A (en) 2003-03-05 2004-12-16 Senesco Technologies Inc Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
AU2004258070B2 (en) * 2003-06-06 2008-12-11 Senesco Technologies, Inc. Inhibition of apoptosis-specific elF-5A ("elF-5A1") with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics
CA2717637A1 (en) 2008-03-07 2009-09-17 Senesco Technologies, Inc. Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide
US8445638B2 (en) 2008-09-03 2013-05-21 Senesco Technologies, Inc. Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells

Also Published As

Publication number Publication date
HUP9801681A2 (hu) 1998-10-28
FI972763L (fi) 1997-10-10
AU4665196A (en) 1996-09-04
WO1996025492A1 (en) 1996-08-22
PL321239A1 (en) 1997-11-24
FI972763A7 (fi) 1997-10-10
FI972763A0 (fi) 1997-06-26
CZ255397A3 (cs) 1998-02-18
MX9705757A (es) 1998-07-31
IL117113A0 (en) 1996-06-18
EP0811060A1 (en) 1997-12-10
HUP9801681A3 (en) 2000-10-30
KR19980702160A (ko) 1998-07-15
BR9606951A (pt) 1997-10-28
NO973679L (no) 1997-10-13
CN1173897A (zh) 1998-02-18
SK109997A3 (en) 1998-04-08
JPH10509327A (ja) 1998-09-14
NO973679D0 (no) 1997-08-11

Similar Documents

Publication Publication Date Title
US8197821B2 (en) Human immunodeficiency virus integrase—Transportin—SR protein—protein interactions
US7485456B1 (en) Modulators of TNF receptor associated factor (TRAF), their preparation and use
US8008451B2 (en) Antibodies to TNF (tumor necrosis factor) receptor family members
US5688511A (en) Cellular protein TDP-43 and regulation of HIV-1 gene expression
CA2210538A1 (en) Eukaryotic initiation factor 5a (eif-5a) mutants
US20090075889A1 (en) Iren protein, its preparation and use
US6338949B1 (en) Nucleic acids encoding receptor recognition factor stat4 and methods of use thereof
US7157552B2 (en) Mutant trichosanthin
AU8072194A (en) Receptor recognition factors, protein sequences and methods of use thereof
US5869247A (en) Natural resistance associated macrophage protein and uses thereof
AU685124B2 (en) Human-derived tumor cell growth inhibitors.
JPS63503356A (ja) ヒトｔ細胞リンパ球向性ウイルス（ｈｔｌｖ‐３）逆転写酵素の発現及びその使用
AU777774B2 (en) Novel method for identifying antibacterial compounds
AU767967B2 (en) Modulators of TNF receptor associated factor (TRAF), their preparation and use
US20030008356A1 (en) Novel polypeptide, a cDNA encoding the same, and use of it
US20080045451A1 (en) Novel thymidylate synthase mutants
US20020165350A1 (en) Novel polypeptide, a method of producing it, and utility of the polypeptide
KR20060011602A (ko) ＨＩＶ ｐｓｉ에 대한 결합력이 증가된 ＮＣ 돌연변이체및 이를 함유하는 약학적 조성물
JPS6133200A (ja) γ−インタ−フエロン
AU5969094A (en) Agents for the prevention and treatment of hiv replication and aids in humans
JPH1118779A (ja) 新規核酸及びそのエイズ発症抑制剤としての用途
KR20040108553A (ko) 녹색 형광 단백질과 Ｂｆｌ-1의 융합단백질 또는 이를코딩하는 유전자를 포함하는 세포사멸을 유도하기 위한약학 조성물
JPWO1994001549A1 (ja) ル−プ型、ヘアピン型リポザイム

Legal Events

Date Code Title Description
FZDE Discontinued